Hydrocinnamic Acid From Candida albicans : Isolation, Characterization, and Antibacterial Activity Against Multidrug‐Resistant Bacteria
Biomedical Chromatography · 2026-07 · 40 (7)
DOI: 10.1002/bmc.70505 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 07.06.2026. Verfasst von Megharethnam Kaviraj und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Advanced Studies in Botany, University of Madras, Chennai, India. Hauptthemen laut MEDLINE: Candida albicans, Anti-Bacterial Agents, Phenylpropionates. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Rashtriya Uchchatar Shiksha Abhiyan.
Abstract (Originalsprache)
Microbial secondary metabolites remain an important source of structurally diverse bioactive compounds with huge therapeutic potential. Yeasts, particularly Candida albicans , possess remarkable metabolic plasticity; thus, it paves the way for identifying antibacterial substances from their extracellular metabolome as it remains underexplored. In the present study, a semi‐preparative high‐performance liquid chromatography (HPLC) method was developed and optimized for the efficient isolation and purification of hydrocinnamic acid (3‐phenylpropionic acid) from the extracellular metabolite extract of C. albicans . The purified compound was characterized using UV–Vis, FTIR, NMR ( 1 H and 13 C), GC–MS, and X‐ray diffraction analyses. This study represents the first report of hydrocinnamic acid isolated and purified from the extracellular metabolites of C. albicans . The antibacterial potential of the purified hydrocinnamic acid was assessed against multidrug‐resistant (MDR) strains of Staphylococcus aureus , Enterobacter cloacae , and Escherichia coli , which exhibited concentration‐dependent inhibition against all tested pathogens, with distinct activity against S. aureus and E. cloacae . The minimum inhibitory concentrations were 10 μg/mL for S. aureus , 15 μg/mL against E. cloacae , and 40 μg/mL against E. coli . Collectively, these results underscore the unexplored antibacterial potential of C. albicans ‐derived extracellular metabolites and position hydrocinnamic acid as a promising natural candidate for combating multidrug‐resistant bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Advanced Studies in Botany, University of Madras, Chennai, India.
- Centre for Integrative Medical Research (CIMR), Sree Balaji Medical College and Hospital, Chennai, India.
ORCID-Profile: Megharethnam Kaviraj, K R Jayappriyan, Rathinam Raja
Förderung
- Rashtriya Uchchatar Shiksha Abhiyan
Zitieren
APA
Kaviraj, M., Jayappriyan, K. R., & Raja, R. (2026). Hydrocinnamic Acid From Candida albicans : Isolation, Characterization, and Antibacterial Activity Against Multidrug‐Resistant Bacteria. Biomedical Chromatography, 40(7). https://doi.org/10.1002/bmc.70505
Vancouver
Kaviraj M, Jayappriyan KR, Raja R. Hydrocinnamic Acid From Candida albicans : Isolation, Characterization, and Antibacterial Activity Against Multidrug‐Resistant Bacteria. Biomedical Chromatography. 2026;40(7). doi:10.1002/bmc.70505
BibTeX
@article{Kaviraj2026,
author = {Kaviraj, Megharethnam and Jayappriyan, K R and Raja, Rathinam},
title = {Hydrocinnamic Acid From Candida albicans : Isolation, Characterization, and Antibacterial Activity Against Multidrug‐Resistant Bacteria},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {7},
doi = {10.1002/bmc.70505}
}
EUVIMED